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Summary
We consider conditional estimation in two-stage sample size adjustable designs and the consequent
bias. More specifically, we consider a design which permits raising the sample size when interim results
look rather promising, and which retains the originally planned sample size when results look very
promising. The estimation procedures reported comprise the unconditional maximum likelihood,
the conditionally unbiased Rao-Blackwell estimator, the conditional median unbiased estimator, and
the conditional maximum likelihood with and without bias correction. We compare these estimators
based on analytical results and a simulation study. We show how they can be applied in a real clinical
trial setting.
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1 Introduction
Adaptive design has made its way into the repertoire of practical clinical biostatistics as shown for example
by the review of [Bretz et al., 2009] and the discussion by [Iasonos and O’Quigley, 2014]. European and
US guidance documents for the use of adaptive designs in clinical trials have been developed. Adaptive
designs are applied in the confirmatory context (Phase III) as well as in earlier development. For example,
adaptive Phase II or seamless Phase II/III case studies have been described by [Miller et al., 2014] and
[Cuffe et al., 2014].
In this article, we consider recalculation of the sample size based on an interim effect estimate. For this
adaptive design, statistically valid methods are required for inference. Much work has been done in recent
decades to provide significance tests which adequately control the type I error rate in the context of sample
size recalculation. For example, conditions have been identified by [Posch et al., 2003] and [Broberg, 2013]
where the conventional significance test (which would be done in a non-adaptive situation) still controls
the type I error rate after sample size recalculation. In these references, the general conditional error
approach is applied, which states that adaptations are allowed as long as the conditional error rate of the
final test is not increased by the adaptation, see [Mu¨ller and Scha¨fer, 2001, Mu¨ller and Scha¨fer, 2004].
Alternatively, if it is not desired to adhere to these conditions, several good methods exist to control the
type I error with modified significance tests in this adaptive setting.
However, point and interval estimates are usually of high importance for clinical interpretation of trial
results. It has been identified that inference in adaptive designs needs to focus more on estimation, which
according to [Bretz et al., 2009] is a topic of ongoing research.
Estimation has been considered for treatment selection designs where, in an interim analysis, treat-
ment(s) with best (largest) estimates are selected for Stage 2. It is well known that the naive effect
estimate of the treatment with best interim result is positively biased due to selection. This and the
bias after more complex selection situations is discussed by [Bauer et al., 2010]. To tackle this prob-
lem, estimation under the condition of the order statistics of interim means has been investigated.
[Cohen and Sackrowitz, 1989] derived a conditional Rao-Blackwell estimator. [Kimani et al., 2013] gen-
eralised this to allow for a futility stop and developed an estimator correcting the unconditional maximum
likelihood estimate (MLE) for its conditional bias; [Robertson et al., 2016] generalized to a multivariate
normal setting with known covariance structure. [Carreras and Brannath, 2013] and [Bowden et al., 2014]
use shrinkage estimators to address selection bias.
In contrast to the mentioned publications on treatment selection, we investigate here an interim
decision rule for sample size recalculation where sample size depends on the estimated effect in Stage 1.
Instead of treatment selection bias, a bias can occur here in the unconditional case due to data dependent
weighting of the stages. In this article we focus on inference under the condition that a specific sample
size is chosen. [Koopmeiners et al., 2012] consider the case of two possible sample sizes: futility stop
or continue to a prespecified sample size. They present conditional Rao-Blackwell, conditional median
unbiased and conditional MLE. We extend the design allowing for a finite (usually low) number of
possible sample size decisions. In the [Koopmeiners et al., 2012] setting it is heuristically clear that the
three conditional estimators are smaller than the unconditional MLE under the condition of continuation.
In contrast, the relation between the estimates is not obvious for the sample size recalculation design of
this paper. We will prove a result pinpointing when the conditional estimators are larger or smaller than
the unconditional MLE leading to a general insight how these conditional estimates behave.
Further to the estimators considered by [Koopmeiners et al., 2012] we motivate and investigate here
a new estimator where we bias-correct the conditional MLE, employing a new bias approximation using
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the third derivative of the log-likelihood.
In contrast to the mentioned publications on treatment selection, we will compare here all four con-
ditional estimators mentioned above and the unconditional MLE head-to-head with regard to their bias,
variance and mean squared error (MSE) by simulations for our sample size recalculation design. Unlike
these treatment selection publications and unlike [Koopmeiners et al., 2012], we compare not only average
measures (bias, variance, MSE) but also differences between the estimators on an individual data level as
we describe the conditional estimators as functions of the unconditional MLE. We can order conditional
Rao-Blackwell, conditional median unbiased and conditional MLE in terms of how much they differ from
MLE.
In this article, we will consider the case of normally distributed data with known variance. In Section
2, we provide the general assumptions and the considered sample size recalculation rule, discuss bias of
the MLE and mention unconditionally unbiased estimates. We derive several conditional estimators in
Section 3 and compare them in Section 4. Section 5 provides extensions to our model. For a previously
conducted randomized controlled clinical trial which investigated a treatment for schizophrenia patients,
we show how the considered estimators can be applied in Section 6. A discussion concludes in Section 7.
2 Background
2.1 General setting and bias
We consider the one-sample case with independent normally distributed observations. Let the observa-
tions be X1, X2, · · · ∼ N(µ, σ2) with σ2 known. An interim analysis is performed after n1 observations
(Stage 1) and based on the results, the sample size N2 for Stage 2 is determined; the total sample
size is N = n1 + N2 (note that N2 and N are random variables). We use the simplified notation
Y1 =
∑n1
i=1Xi/n1, σ1 = σ/
√
n1; Y2 =
∑N
i=n1+1
Xi/N2 represents the additional information collected
after the interim analysis, σ2 = σ/
√
N2.
In a study with the aim to test H0 : µ ≤ 0 versus H1 : µ > 0, the parameter µ should be estimated
by a µ̂ after all N observations. The mean of all observations is the unconditional maximum likelihood
estimate (MLE) for µ. Therefore, we write µ̂ML = Y =
∑N
i=1Xi/N and further, σ0 = σ/
√
N . Note
that σ0, σ1, σ2 (as well as σA and σB introduced later) are all multiples of σ which we use to improve
readability of formulae.
[Brannath et al., 2006] show that estimators of the form µ̂WM,w = w(Y1)Y1 + {1 − w(Y1)}Y2 with
w(Y1) ∈ [0, 1], i.e. a weighted mean of Y1 and Y2 where the weight w may depend on the first stage
outcome, have bias Cov {w(Y1), Y1} for all µ.
Choosing the Stage 2 sample size N2 = N2(Y1) as a decreasing function of Y1 > 0 is a natural choice
as larger sample sizes are needed if the true µ > 0 is small. If one uses µ̂ML which is equal to µ̂WM,w with
w(Y1) = n1/{n1 +N2(Y1)}, the result of [Brannath et al., 2006] therefore shows that µ̂ML overestimates
µ under µ > 0.
In this paper, we consider the following design: We decide in the interim analysis to stop for futility
if the observed effect Y1 is low (decision R = 0 and final sample size n
(0)
tot ≥ n1); otherwise we make one
out of s decisions where decision R = t means that sample size n
(t)
tot, t = 1, . . . , s, is chosen depending on
in which of s predefined intervals Y1 is. Formally,
R = t and N = N(Y1) = n
(t)
tot if ct < Y1 ≤ ct+1, t = 0, 1, . . . , s (1)
for s ≥ 2 and some constants c0 = −∞ ≤ c1 < · · · < cs ≤ cs+1 =∞.
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To simplify the presentation, we subsequently consider the case s = 2 – however, all our results are
directly applicable for s > 2 as well. We write therefore:
R =

0
1
2
and N = N(Y1) =

nf if Y1 ≤ c1
nmax if c1 < Y1 ≤ c2
n0 if Y1 > c2
(2)
where n0 = n
(2)
tot, the originally planned sample size, nmax = n
(1)
tot, the maximal sample size increased
from the planned (since observed effect was promising but limited), and nf = n
(0)
tot, the sample size in
case of a futility stop. Usually nf = n1 is desired but sometimes this is not possible in practice and an
“overrun” nf > n1 needs to be accepted. Note that a common two-stage group sequential design without
sample size recalculation is an important special case of (2) with nf = n0 = n1 (or allowing overrun,
nf = n0 ≥ n1).
In the design (2), the bias of µ̂ML = µ̂WM,w with w(Y1) = n1/N = n1/N(Y1) is:
Cov {w(Y1), Y1} = E {w(Y1)Y1} − E {w(Y1)}E (Y1) = n1E (Y1/N)− E (n1/N)E (Y1)
= n1σ1
{
−φ(
c1−µ
σ1
)
n1
− φ(
c2−µ
σ1
)− φ( c1−µσ1 )
nmax
+
φ( c2−µσ1 )
n0
}
,
where φ and Φ denote the density and the distribution function of the standard normal distribution,
respectively.
For example for n1 = 50, n0 = 100, nmax = 150, σ = 1, the bias of µ̂ML in dependence of µ is shown
in Figure 1 for some choices of (c1, c2). The bias is negative around c1 (where the sample size increases
from Y1 < c1 to Y1 > c1) and is positive around c2 (where the sample size decreases from Y1 < c2 to
Y1 > c2). When c1 and c2 are very close (e.g. c1 = 1, c2 = 1.1, lower right panel), the positive bias can
almost be hidden by the overlying negative bias.
2.2 Unconditionally unbiased estimates of the treatment effect
We can search for estimates µ̂ which are unbiased in the traditional, unconditional sense, i.e. E(µ̂) = µ,
by choosing appropriate weight functions w(Y1) for µ̂WM,w. If the trial cannot stop at the interim, i.e.
c1 = −∞, nmax > n1, n0 > n1, then any predetermined weights, w(Y1) = w1 and 1 − w1, will ensure
an unbiased estimate µ̂ = w1Y1 + (1 − w1)Y2. According to [Chang, 2007], a good choice are weights
w1 = 2n1/(n0 + nmax). For designs permitting early stopping, [Lawrence and Hung, 2003] present the
median unbiased estimate µ̂ = (w1
√
n1Y1 + w2
√
N2Y2)/(w1
√
n1 + w2
√
N2), for predetermined weights
w1, w2, suggested to be w1 =
√
n1/n0 and w2 =
√
1− w21 . We will subsequently not restrict ourselves
to predetermined weights, but will permit the weights to change due to adaptations.
3 Conditional estimation after sample size recalculation
If the consequences of bias are different depending on the interim decision R, conditional estimation
is sensible. In studies with an interim decision about futility stop only (c2 = ∞, i.e. R ∈ {0, 1}), it
is reasonable to require unbiasedness specifically if the trial is continued to Stage 2 (R = 1). Only
if not stopped for futility, results are used by regulatory agencies for decisions about licensing or if a
Phase II trial is considered by the sponsor for decisions about continuation of the program to Phase
III. Therefore, [Pepe et al., 2009] advocate requiring unbiasedness under the condition that the trial is
continued, E(µ̂|R = 1) = µ.
Broberg & Miller: Conditional Estimation in Adaptive Designs 5
0.0 0.5 1.0 1.5
−
0.
04
0.
00
µ
bi
as
c1 = − ∞, c2 = 0
0.0 0.5 1.0 1.5
−
0.
04
0.
00
µ
bi
as
c1 = 0, c2 = 1.2
0.0 0.5 1.0 1.5
−
0.
04
0.
00
µ
bi
as
c1 = 0.9, c2 = 1.2
0.0 0.5 1.0 1.5
−
0.
04
0.
00
µ
bi
as
c1 = 1, c2 = 1.1
Figure 1: Bias of the maximum likelihood estimator µ̂ML in dependence of µ for different values of c1, c2
as indicated above each panel and for n1 = 50, n0 = 100, nmax = 150, σ = 1. The vertical dotted lines
indicate c1 and c2.
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However, in our situation with decision rule (2), i.e. when based on an observed large effect the study
is continued to a smaller sample size or stopped directly, the situation is a little more complex. The
interesting situations when good properties of estimators are required are both R = 1 and R = 2. We
therefore investigate the bias under the condition of R and show how to make the analysis unbiased in
the conditional setting. Cases R = 1 and R = 2 are of main interest, hence we do not subsequently
consider R = 0.
3.1 The unconditional MLE
We will first consider the unconditional MLE µ̂ML (= Y ). The conditional distribution is presented in
Section 3.3. The conditional bias of µ̂ML equals
biasML(µ,R) =
 σ
√
n1
N
φ(b1)−φ(b2)
Φ(b1)−Φ(b2) , R = 1,
σ
√
n1
N
φ(b2)
Φ(b2)
, R = 2,
(3)
where bi = bi(µ) = (µ− ci)/σ1, i = 1, 2, cf. (13.133) and (13.134) in [Johnson et al., 1994]. When R = 1
we have the following relations. If µ < (c1+c2)/2, then biasML > 0. If µ > (c1+c2)/2, then biasML < 0.
Whenever R = 2 there is a positive bias. However, since µ is unknown we cannot calculate this bias in
practice. There is another way to construct an unbiased estimator which builds on the Rao-Blackwell
theorem.
3.2 Uniformly Minimum Variance Unbiased Estimation
In the context of treatment selection designs, the Rao-Blackwell theorem has been used to find an Uni-
formly Minimum Variance Unbiased Estimator, under the condition of the order statistics of interim
means, [Cohen and Sackrowitz, 1989, Bowden and Glimm, 2008]. [Kimani et al., 2013] have additionally
conditioned on proceeding to Stage 2 since they allowed for futility stopping. For further generalisations
see [Bowden and Glimm, 2014, Robertson et al., 2016]. In these treatment selection designs, the sample
size of Stage 2 is given and one proceeds to Stage 2, selecting the best treatment(s) and dropping the
others.
We will now derive results for the case of our sample size recalculation design without selection. We
condition here on the interval which the observed interim effect is in and not on an order statistic of
interim means.
The following theorem presents the Uniformly Minimum Variance Conditionally Unbiased Estimator
(UMVCUE) and its conditional variance. The estimator consists of two terms: the unconditional MLE
µ̂ML and a product of a standard deviation and a ratio involving φ and Φ, which in the case of R = 2 is
equal to the inverse Mills ratio ν(x) = φ(x)/Φ(x). The unbiasedness is achieved by subtracting a term
which has a structure similar to the bias (3). The proof can be found in Web Appendix A.
Theorem: The UMVCUE µ̂RB is given by
µ̂RB =
{
g1(µ̂ML) = µ̂ML − σB ∆φ∆Φ , R = 1,
g2(µ̂ML) = µ̂ML − σBν(z2), R = 2,
(4)
where ∆φ = φ(z1) − φ(z2), ∆Φ = Φ(z1) − Φ(z2), zi = zi(µ̂ML) = (µ̂ML − ci)/σA, i = 1, 2, and σ2A =
σ41/(σ
2
1 + σ
2
2), σ
2
B = σ
4
2/(σ
2
1 + σ
2
2). The conditional variance is given by:
V ar(µ̂RB |R) ≈
{
g′1(µ1)
2V ar(µ̂ML|R = 1), R = 1,
g′2(µ2)
2V ar(µ̂ML|R = 2), R = 2,
(5)
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where
g′1(y) = 1 +
σ22
σ21
{z1(y)φ(z1(y)) + z2(y)φ(z2(y))}∆Φ+∆φ2
∆Φ2
,
g′2(y) = 1 +
σ22
σ21
z2(y)φ(z2(y))Φ(z2(y)) + φ(z2(y))
2
Φ(z2(y))2
,
and the variance factors in (5) are detailed in the proof in formulae (A.1) and (A.2) in Web Appendix A.
Note that the values of σ2, σA, σB are different for case R = 1 and R = 2 since they depend on N2.
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Figure 2: Difference between Rao-Blackwell (RB) and maximum likelihood (ML) estimator versus ML
estimator for R = 1 (left) and R = 2 (right). Here n1 = 50, n0 = 100, nmax = 150, c1 = 0.9, c2 = 1.2, σ =
1. The vertical dotted lines indicate c1 and c2.
To illustrate the difference between the Rao-Blackwell estimate in the above theorem and the MLE,
we show µ̂RB− µ̂ML versus µ̂ML for R = 1 and R = 2, see Figure 2, with the specific values n1 = 50, n0 =
100, nmax = 150, c1 = 0.9, c2 = 1.2 and σ = 1. For example let us look at R = 1, i.e. when we have
0.9 < Y1 < 1.2 for the interim mean. Then the total sample size is raised from n0 = 100 to nmax = 150.
If the final mean, µ̂ML, is still between 0.9 and 1.2, the MLE and the Rao-Blackwell differ by at most
0.05. If µ̂ML > 1.2, then the Rao-Blackwell estimate is larger than the MLE and if µ̂ML < 0.9, then the
Rao-Blackwell estimate is smaller than the MLE; this means in both cases: µ̂RB is shrunken towards Y2.
In Figure 2 for R = 1, µ̂RB − µ̂ML > 0 if and only if µ̂ML > 1.05. Note that 1.05 is the mean of c1
and c2. Further we observe that µ̂RB − µ̂ML < 0 for R = 2. These observations are valid in general, see
Section 4.
Let us consider in general what happens for the case R = 1 if the interval (c1, c2] becomes small. If
c2 → c1, µ̂RB will approach Y2. This follows as µ̂RB = E(Y2|Y, Y1 ∈ I) = E(Y2|Y, Y2 ∈ J), see Web
Appendix A.
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3.3 Conditional median unbiased Estimation
The conditional median unbiased estimation comes naturally from interval estimation and is the solution
with respect to µ for q = 0.5 of the equation∫ µ̂ML
−∞
f (y|µ,R)dy = q, (6)
cf. [Koopmeiners et al., 2012] and [Whitehead, 1992]. It will be denoted by µ̂CMU . Note that interval
estimation can be achieved by solving for q1 and q2 with q2 > 0.5 > q1 such that q2− q1 = l is the desired
confidence level.
Take the case R = 1 first. As in the derivation of the Rao-Blackwell estimator we may show that the
joint density for Y1 and Y under the condition may be written as
f(y1, y) = k˜(µ)φ
(
y − µ
σ0
)
φ
(
y1 − y
σA
)
1{c1 < y1 ≤ c2}
with a function k˜(µ) independent of y1 and y. Integrating out y1 yields the conditional density:
f(y|µ,R = 1) =
Φ
(
c2−y
σA
)
− Φ
(
c1−y
σA
)
Φ
(
c2−µ
σ1
)
− Φ
(
c1−µ
σ1
) · φ
(
y−µ
σ0
)
σ0
,
see also (13.133) in [Johnson et al., 1994]. From this the case R = 2 follows:
f(y|µ,R = 2) =
1− Φ
(
c2−y
σA
)
1− Φ
(
c2−µ
σ1
) · φ
(
y−µ
σ0
)
σ0
,
cf. equation (2) in [Koopmeiners et al., 2012].
Building on [Koopmeiners et al., 2012] one may derive an approximate bias formula for µ̂CMU . Using
equation (8) in [Koopmeiners et al., 2012] we write
0.5 ≈ F (µ̂ML|µ,R) + (µ̂CMU − µ)∂F (µ̂ML|µ,R)
∂µ
.
To denote the conditional expectation of µ̂ML use the notation µR = µ + biasML(µ,R), where the bias
is specified in equation (3). This means that the bias approximately equals
biasCMU (µ,R) = E(µ̂CMU − µ|µ,R) ≈ 0.5− F (µR|µ,R)∂F (µR|µ,R)
∂µ
. (7)
For R = 1, the derivative equals
∂F (x|µ,R = 1)
∂µ
=
∫ x
−∞
f(t|µ,R = 1)
 t− µ
σ20
+
φ( c2−µσ1 )− φ(
c1−µ
σ1
)
σ1
{
Φ( c2−µσ1 )− Φ(
c1−µ
σ1
)
}
 dt. (8)
Then evaluate at x = µ1, with µ1 = µ+biasML(µ, 1), and similarly for R = 2. The delta method provides
an estimate of the variance through
V ar(µ̂CMU |µ,R) ≈
{
∂
∂x
0.5− F (x|µ,R)
∂F (x|µ,R)
∂µ
|x=µR
}2
V ar(µ̂ML|µ,R).
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3.4 Conditional maximum likelihood estimation
[Bebu et al., 2010, Bebu et al., 2013] address conditional maximum likelihood estimation in a two-stage
adaptive design with treatment selection. Here, instead, we permit two kinds of continuation to the
second stage, either with or without sample size adjustment, and, we derive an explicit bias correction
formula.
To derive the likelihood function given R = 1, we write bi = bi(µ) =
√
n1(ci−µ)/σ, i = 1, 2, and then,
P (R = 1) = P (c1 < Y1 ≤ c2) = Φ(b2(µ)) − Φ(b1(µ)). (9)
The likelihood function is the product of a constrained multivariate distribution (for Stage 1) and an
unconstrained (for Stage 2):
LR(µ) =

n1∏
j=1
1
σ
φ
(
xj − µ
σ
) · 1{R = 1}P (R = 1) ×
N∏
j=n1+1
1
σ
φ
(
xj − µ
σ
)
.
Then the log likelihood becomes
LR(µ) = −N log(
√
2πσ)−
N∑
j=1
(xj − µ)2
2σ2
− log(Φ(b2(µ)) − Φ(b1(µ))).
Taking the derivative L ′R(µ) = ∂LR(µ)/∂µ with respect to µ and using b
′
i(µ) = −
√
n1/σ yields
L
′
R(µ) =
N∑
j=1
xj − µ
σ2
+
√
n1
σ
φ (b2(µ)) − φ (b1(µ))
Φ (b2(µ)) − Φ (b1(µ)) . (10)
Note that the last term of L ′R(µ) equals −N × biasML(µ,R)/σ2, and that the expected value of the first
is N × biasML(µ,R)/σ2. So, E(L ′R(µ)|R) = 0, cf. Lemma 6.1 of [Lehmann, 1983].
Solving the optimality condition
σ2L ′R(µ) = N(µ̂ML − µ) +
√
n1σ
φ (b2(µ))− φ (b1(µ))
Φ (b2(µ))− Φ (b1(µ)) = 0 (11)
with respect to µ yields the conditional maximum likelihood estimate µ̂CML.
An estimate of the variance of the estimator may be obtained through the observed information j
j(µ̂CML) = L
′′
R(µ)|µ=µ̂CML = −
N
σ2
+
b2v2 − b1v1
sr
+
(v2 − v1)2
r2
|µ=µ̂CML ,
with s = σ/
√
n1, vi = φ (bi(µ)) /s, bi = bi(µ) and r = P (R = 1) = Φ(b2) − Φ(b1). This gives us the
variance estimate −j(µ̂CML)−1. Since µ̂CML asymptotically attains the the Crame´r-Rao bound and
unbiasedness, one could consider estimating also V ar(µ̂RB |R) by −j(µ̂CML)−1. For a comparison of
different estimators see [Lane et al., 2014].
As explained in [Cox and Barndorff-Nielsen, 1994] the bias of the MLE is related to the first three
derivatives of the log likelihood. The derivation in Web Appendix A gives the following bias formula (for
a closed form presentation of L ′′′R (µ) see Web Appendix A):
biasCML(µ,R) = L
′′′
R (µ)/{2L ′′R(µ)2}+O(N−3/2). (12)
A bias corrected estimate µ̂CMLc comes from solving the equation
µ̂CML = µ+ biasCML(µ,R) (13)
with respect to µ, cf. equation (5.6.1) in [Whitehead, 1992]. We also tested µ˜CMLc = µ̂CML −
biasCML(µ̂CML, R), but the results were almost identical (data not shown).
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4 Comparison between conditional estimators
When we compare the conditional estimators discussed above with the unconditional MLE µ̂ML, we can
show the following theorem. The proof can be found in Web Appendix A.
Theorem Let µ̂ ∈ {µ̂RB, µ̂CMU , µ̂CML}. If R = 1, then
µ̂

<
=
>
 µ̂ML if µ̂ML

<
=
>
 c1 + c22 .
If R = 2 then µ̂ < µ̂ML.
We calculate µ̂RB as a function g of µ̂ML, see (4), and visualize the difference between µ̂RB and µ̂ML in
Figure 2. Next we investigate the difference between the conditional estimators, µ̂RB, µ̂CMU , µ̂CML, µ̂CMLc.
Through formulae (6), (11), we have implicit representations of µ̂CMU , µ̂CML as functions of µ̂ML, re-
spectively; formula (13) together with (11) implicitly define µ̂CMLc as a function of µ̂ML. We have
computed these functions numerically and show pairwise differences between the conditional estimators
in Figure 3, here for n1 = 50, n0 = 100, nmax = 150, c1 = 0.9, c2 = 1.2, σ = 1. The largest difference
between µ̂CMU and µ̂RB in this scenario is for R = 2 and µ̂ML ≈ 1.32 and is −0.0066. Compared to
the difference between µ̂RB and µ̂ML seen before, this is a quite small difference. The difference between
µ̂CML and µ̂RB is a little larger but still at most 0.01. We see that we can order the estimators in
terms of how much they correct the ML: µ̂RB, µ̂CMU , µ̂CML (from smaller to larger absolute difference to
MLE). This is parallel to the unconditional case where the median unbiased estimator is a compromise
between the mean unbiased estimator and the unconditional MLE, see [Bretz et al., 2009], Section 6.2.
The bias-corrected µ̂CMLc is very similar to µ̂RB .
When analysing differences between estimators for other scenarios, we see that these are often very
small. The estimators differ slightly more when n0 − n1 and nmax − n0 are smaller. In Web Appendix
D, we show the differences for a few other scenarios.
4.1 Simulation study
To assess average performance of the estimators, we simulated normal data for a number of scenarios
and replicated a large number of times (1,000,000). In each replication the outcome of Y1 defined R and
thereby decided the final design according to formula (2). Without loss of generality σ was kept fix at 1.
We also fixed the value c1 = 0.9 as results depend only on the differences between the values µ, c1 and c2.
We then varied µ over {0.9, 1, 1.2, 1.4} and c2 over {1.2, 1.3}. The maximal patient number (used when
R = 1) was defined as nmax = 150 throughout, and n0 was set to n1 + 50, while n1 varied over {50, 70}.
These scenarios are presented in Table 1, and some further scenarios in Web Appendix F and G.
In Table 1 the methods are denoted as follows: Rao-Blackwell (RB), conditional median unbiased
(CMU), conditional MLE (CML), bias corrected conditional MLE (CMLc), unconditional MLE (ML).
In the simulations the CMLc used the correction biasCML(µ̂|R) from equations (12) and (13). The table
provides observed bias, variance and mean squared error (MSE) conditional on R = 1 and R = 2 as well
as the number s of replications with R = 1 and R = 2, respectively.
Among the methods there is a high degree of concordance. From a practical point of view one could
argue that MSE should take precedence over both bias and variance. As judged by MSE the methods
RB, CMU, CML, and CMLc perform equally well. If we require strict conditional unbiasedness, then of
course Rao-Blackwell is the only option.
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Figure 3: Difference between conditional estimators and Rao-Blackwell (RB). Grey line: conditional
median unbiased - RB; Black line: conditional maximum likelihood (CML) - RB; Black dotted line: cor-
rected CML - RB. All plotted versus maximum likelihood (ML) estimate. Here n1 = 50, n0 = 100, nmax =
150, c1 = 0.9, c2 = 1.2, σ = 1. The vertical dotted lines indicate c1 and c2.
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Table 1: Summary of bias and variation. Here n0 = n1 + 50, nmax = 150, c1 = 0.9, σ = 1. 1000,000
simulations. The values for µ, n1, c2 are chosen in 4 scenarios according to the values noted in the table.
The number of simulation runs with R = 1 or R = 2 is s.
µ n1 c2 Case Method Bias Var MSE
1 50 1.2 R=1 RB 0.000 0.009 0.009
s= 682108 CMU -0.000 0.009 0.009
CML -0.000 0.009 0.009
CMLc 0.000 0.009 0.009
ML 0.011 0.005 0.005
R=2 RB 0.001 0.017 0.017
s= 78778 CMU -0.002 0.017 0.017
CML -0.004 0.017 0.017
CMLc 0.001 0.017 0.017
ML 0.132 0.006 0.023
1.2 70 1.2 R=1 RB -0.000 0.010 0.010
s= 494010 CMU 0.002 0.010 0.010
CML 0.003 0.010 0.010
CMLc 0.000 0.010 0.010
ML -0.043 0.005 0.006
R=2 RB 0.000 0.013 0.013
s= 499857 CMU -0.007 0.013 0.013
CML -0.010 0.013 0.013
CMLc -0.000 0.013 0.013
ML 0.056 0.005 0.008
1.4 50 1.3 R=1 RB 0.000 0.009 0.009
s= 239373 CMU 0.001 0.009 0.009
CML 0.002 0.009 0.009
CMLc 0.000 0.009 0.009
ML -0.061 0.005 0.009
R=2 RB 0.000 0.013 0.013
s= 760435 CMU -0.005 0.013 0.013
CML -0.008 0.013 0.013
CMLc -0.001 0.013 0.013
ML 0.029 0.008 0.009
0.9 50 1.2 R=1 RB -0.000 0.009 0.009
s= 482187 CMU -0.001 0.009 0.009
CML -0.001 0.009 0.009
CMLc -0.000 0.009 0.009
ML 0.035 0.005 0.006
R=2 RB -0.001 0.018 0.018
s= 16968 CMU -0.003 0.018 0.018
CML -0.005 0.017 0.017
CMLc -0.001 0.018 0.018
ML 0.175 0.005 0.036
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However, we observe that the naive unconditional MLE does quite well. This has been previously
mentioned in the case of sample size recalculation, see [Brannath et al., 2006]. In our simulations, the
MLE performs best under R = 1. If the true mean µ is large, the MLE also performs well under R = 2
(see second and third scenario in Table 1). In cases when µ is small but R = 2 happened anyway, the
conditional MSE of the MLE is larger than for the other estimators (see first and last scenario in Table
1). Note that R = 2 happened in 8% and 2% of the simulations in these two scenarios, respectively.
We have compared the simulated bias in Table 1 with the theoretical biases from (3), (7) and (12). The
theoretical biases for ML (3) and CML (12) are confirmed by the simulations. In contrast, approximation
(7) based on the delta method appears inaccurate.
4.2 Asymptotic distribution
Noting that, as n1 → ∞, µ ∈ (c1, c2) implies P (R = 1) → 1, and, µ > c2 implies P (R = 2) → 1, one
may prove the asymptotic conditional normality of µ̂ML as n1, n2 → ∞. These asymptotics show up in
several of the simulation scenarios, see Web Appendix I. In some cases, slight deviations from the normal
distribution are still visible for the finite sample sizes. Regarding µ̂RB = gi(µ̂ML) (for R = i, i = 1, 2),
we note that gi is close to linear. The asymptotic conditional normality of µ̂ML therefore leads to the
asymptotic conditional normality of µ̂RB . It appears in the simulation results in Web Appendix I that
asymptotic normality is attained, in some scenarios still with slight deviations for the sample sizes used.
µ̂CMU also roughly follows a conditional normal distribution in the simulation scenarios. We pro-
vide a heuristic argument for this. The distribution of µ̂ML will asymptotically approach a normal
distribution, which has µ as its median, thus µ̂CMU ≈ µ̂ML for large samples. Finally, it can be
proven that
√
NL
′
and consequently µ̂CML tends to a conditional normal distribution as n1, n2 → ∞
[Cox and Barndorff-Nielsen, 1994, Chapter 3, p. 86].
We considered n1, n2 → ∞ here. [Lane and Flournoy, 2012] argue for investigating asymptotics for
finite n1 and n2 →∞. They show that the unconditional distribution of the MLE in their case converges
to a scale mixture of normal random variables.
5 Extensions
Next we discuss several possible generalizations of our basic model.
Consider first the case of unknown variance. Assuming a reasonable sample size, such as in our
scenarios, the common variance is well estimated by the pooled variance estimate S2p =
(n1−1)S21+(n2−1)S22
n1+n2−2 ,
based on the stage-wise variance estimates S21 and S
2
2 . In a new set of simulations we inserted S
2
p instead
of σ2 when computing the conditional estimators in the final analysis. For all 4 scenarios the values for
Bias, Var, MSE were at most 0.001 different from the known-variance case (see Web Appendix E). For
Scenario 4 with R = 2 only, the differences were up to 0.004, which still can be explained by Monte-Carlo
error as the number of repetitions under condition R = 2 was smaller.
The methods of Section 3 extend in an obvious way to any one-parameter MLE θ̂(X), estimating an un-
known parameter θ, noting that P (R = 1) = P
{
c1 < θ̂(X) < c2
}
approximately is Φ
(
−j(θ̂)(c2 − θ̂)
)
−
Φ
(
−j(θ̂)(c1 − θ̂)
)
, cf. (9).
One may further extend our results concerning the one-arm model to two arms by the use of pro-
file likelihood. In a parallel group study the estimation problem may be expressed as follows, cf.
[Whitehead, 1992]. The two independent series of observations obey laws f(x, µ1, η) and f(x, µ2, η),
respectively, where η is a vector of common nuisance parameters. For instance, σ could be one of the
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nuisance parameters. The parameter of interest is the contrast θ = 12 (µ1 − µ2), while ψ = 12 (µ1 + µ2)
becomes one additional nuisance parameter.
Moreover, as in [Bebu et al., 2013] the scenario may be modified to accommodate adjustment for
covariates. For simplicity consider a single covariate t. Assume the individual outcomes Oi = xiβ
′
+ ǫi
with β = (β1, β2, β3) and i.i.d. ǫi ∼ N(0, σ2), xi = (δi1, δi2, ti), where δij = 1 if subject i receives
treatment j and 0 otherwise. We may then replace Y1 by β̂
(1)
1 − β̂(1)2 with β̂
(1)
= (β̂
(1)
1 , β̂
(1)
2 , β̂
(1)
3 ) ∼
N(β, (X
′
(1)X(1))
−1σ2)), where X(1) denotes the design matrix corresponding to the first stage, and Y2
and Y by the corresponding quantities.
Applying normal approximation (see [Whitehead, 1992], Chapter 3.4, or [Jennison and Turnbull, 2000],
Chapter 3.7), our results can be used in the situation of a two-arm time-to-event trial. Here, n1, n0, nmax
are the number of events in both arms rather than number of patients. The normal approximation implies
that − log(ĤR) ∼ N(− log(HR), 4/n) where HR is the true and ĤR the estimated hazard ratio. There-
fore, in our notation, we have σ2 = 4. Note that we assume here additionally to the normal approximation
that the “increment” from Stage 1 to Stage 2 is independent of Stage 1 in the test statistic. This assump-
tion might be challenged in time-to-event trials (see [Jenkins et al., 2011]) as the same patient could e.g.
contribute as a censored patient to Stage 1 and with an event to the increment. Hence, the independence
assumption is an approximation. We illustrate the application of our results to a time-to-event study in
Section 6.
6 Application in a schizophrenia trial
In a randomized, double-blind trial for clinically stable patients with schizophrenia, the treatments que-
tiapine and placebo were compared, [Peuskens et al., 2007]. The primary endpoint was time to first
schizophrenic relapse analysed by a Cox proportional hazards model. An interim analysis was conducted
after 45 relapses observed in total and the final analysis was scheduled after 90 relapses. (We ignore
here for now the second interim which was preplanned – we will discuss this below.) We apply normal
approximation to the survival analysis data and the total number of relapses are treated as sample size.
The trial was preplanned to be stopped when the interim two-sided p-value was < p0 = 0.004455, i.e.
stop for efficacy if p < p0 to the advantage of quetiapine, and stop for futility if p < p0 to the advantage of
placebo. The recruitment was fast, and 61 relapses therefore been observed when the independent Data
and Safety Monitoring Board’s recommendation “stop” or “continue” from the interim analysis could be
announced. The number of 61 relapses was not preplanned; nevertheless, we treat the increase to 61
relapses as an unavoidable consequence of the recruitment process, as it had been planned in advance to
have n0 = 61 relapses.
Using the approximation − log(ĤR) ∼ N(− log(HR), 4/n), we have rule (2) with n1 = 45, n0 =
61, nmax = 90, σ
2 = 4. We obtain c1 =
σ√
n1
Φ−1(p0/2) = −0.848, c2 = −c1 = 0.848.
According to [Peuskens et al., 2007], the observed hazard ratio was 0.16 after 45 relapses and 0.13 after
61 relapses. We have Y1 = − log(ĤR1) = 1.83 in the interim and µ̂ML = 2.04 in the final analysis. In order
to compute the Rao-Blackwell estimator, we compute first σ1 = σ/
√
n1 = 2/
√
45, σ2 = σ/
√
N2 = 1/2,
and σ2A = σ
4
1/(σ
2
1 + σ
2
2) = 0.0233, σ
2
B = σ
4
2/(σ
2
1 + σ
2
2) = 0.1844, leading to µ̂RB = µ̂ML − 10−14 ≈ µ̂ML.
Computing the other conditional estimates shows that in this case with a very clear result and µ̂ML far
from c2, the estimates µ̂CMU , µ̂CML, µ̂CMLc are almost equal to µ̂ML.
Assume that, in contrast to the true trial results, the interim result had just been over the stopping
boundary with an estimated hazard ratio of 0.42 and that after 61 relapses the same estimate was obtained
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(Y1 = µ̂ML = 0.87). This gives µ̂RB = µ̂ML − 0.304 = 0.566 corresponding to a Rao-Blackwell estimated
hazard ratio of exp(−0.566) = 0.57. The estimated hazard ratios with CMU, CML and CMLc are 0.59,
0.60, 0.57, respectively.
In this clinical trial, the result was a stop after interim, R = 2, and we condition on this outcome in
the analysis. It does not matter for the conditional estimates what the design of the study would have
been like if R = 1 had occurred. The above calculated estimates are therefore also valid for the real
situation where a second interim analysis was preplanned.
We made following simulations for this setting: Firstly, we simulated normal data according to the
approximations made here including the idealisation of an independent increments assumption. Secondly,
we simulated the patients’ event times assuming exponential distribution and proportional hazards and
assuming a realistic recruitment speed. At the calendar time when n1 = 45 events were obtained, the
hazard ratio was estimated using Cox regression and Y1 was defined as − log(ĤR1). Here, all patients
were censored at calendar date for interim analysis when they had an event time afterwards. Based on
Y1, the decision for R and N is made. The calendar time is determined when N events are obtained
and the hazard ratio was estimated as previously. Letting Y = − log(ĤR), we defined the increment
statistics Y2 = (N · Y − n1 · Y1)/(N − n1).
The simulation results and more details about simulation assumptions are included in Web Appendix
G. The two ways to simulate produced similar results where the variances and MSEs in case of time-to-
event simulation were slightly larger. The correlation between Stage 1 estimate and increment from Stage
1 to 2 was small, suggesting that the independent increments assumption can be seen as approximately
valid in this situation. However, in the case of other event-time distributions this is not necessarily
fulfilled.
7 Discussion
The naive MLE performs well in the simulations presented here. When comparing the unconditional
MLE used in the conditional setting with the conditional estimators, the former had in many but not in
all scenarios smaller MSE. However the unconditional MLE does not possess any optimality features in
the conditional inference setting. Therefore it is worthwhile searching for alternatives that satisfy certain
optimality criteria relevant to the conditional inference. The difference between the four conditional
estimators was quite small in the scenarios considered. This was also reflected in terms of their bias (they
had little or no bias) and their variance, which was similar. It is therefore not of primary importance
which of these is chosen. The conditional Rao-Blackwell estimator has the advantage that it is unbiased
in construction and has an explicit representation making computation simpler. However, it has to be
pointed out that the situation might be different for nonlinear models where differences between these
types of estimators could be more marked.
We considered a sample size rule with general boundaries c1 < c2. One can choose c1 and c2 to
achieve a certain conditional or predictive power (see e.g. [Jennison and Turnbull, 2000], ch. 10). In
practice, these boundaries can only be a guide for the decision about Stage 2 made by a data monitoring
committee, which also needs to consider safety and other aspects.
In practice, when there is particularly great uncertainty about the variance, it is reasonable to allow
the sample size to depend on the interim variance estimate as well. I.e. in the design specified in (2),
the sample size in case R = 1 would be nmax(S
2
1) where S
2
1 is an interim variance estimate. Conditional
effect estimates for this design are a topic for future research.
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Our results are directly applicable for sample size rules (1) with a finite number of steps, e.g. con-
stant sample sizes between three cut-points c1, c2, c3. However, if an increasing number of cut-points are
introduced, we will condition on more and more information from Stage 1. In the extreme case (for a con-
tinuous sample size recalculation formula) one would condition on the interim observation Y1. This would
imply that the UMVCUE will be µ̂RB = Y2 as mentioned in Section 3.2. [Burman and Sonesson, 2006]
discuss the fact that the information from Stage 1 is no longer used for the conditional estimate.
We point out that the described methods require prespecification of the sample size recalculation rule.
[Graf et al., 2016] determine the maximum bias and MSE of the unconditional MLE when the interim
decision rule is not prespecified. They do this by identifying the worst case sample size rule.
A limitation of this elaboration is that we assumed known variance. In practice, variance is not known
and our methods would be used with estimated variance. We have investigated this for the simulation
study, where we see similar results to known variance; if the sample sizes are large, the stagewise means
are approximately normally distributed. However, in general, alternatives to our assumption of normally
distributed data, t-distribution or other, might be considered in future research.
8 Supplementary Materials
Web Appendices referenced in Sections 3, 4, 5 and 6 are available with this paper at the Biometrics
website on Wiley Online Library: http://onlinelibrary.wiley.com/doi/10.1111/biom.12642/full.
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